Clinician assessments of health status predict mortality in patients with end-stage liver disease awaiting liver transplantation

Liver International

Volumn 35, Issue 9, 2015, Pages 2167-2173

  Lai, Jennifer C ^a   Covinsky, Kenneth E ^a   Hayssen, Hilary ^a   Lizaola, Blanca ^b   Dodge, Jennifer L ^a   Roberts, John P ^b   Terrault, Norah A ^a   Feng, Sandy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Clinical judgment; Health status; Wait list mortality

Indexed keywords

ALBUMIN; SODIUM;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BODY MASS; CHILD PUGH SCORE; CHRONIC HEPATITIS C; CLINICAL ASSESSMENT; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OUTCOME ASSESSMENT; SELF EVALUATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SODIUM BLOOD LEVEL; AGED; HOSPITAL ADMISSION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

AGED; END STAGE LIVER DISEASE; FEMALE; HEALTH STATUS; HUMANS; LIVER TRANSPLANTATION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 84938970428     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12792     Document Type: Article

References (12)

1. Kamath P. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
2. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7-15.
3. Based on OPTN data as of March 15, 2013.
4. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology 2012; 143: 1261-5.
5. McGee DL, Liao Y, Cao G, et al. Self-reported health status and mortality in a multiethnic US cohort. Am J Epidemiol 1999; 149: 41-6.
6. Weissenborn K, Rückert N, Hecker H, et al. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998; 28: 646-53.
7. Volk ML, Hernandez JC, Lok AS, et al. Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007; 13: 1515-20.
8. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.
9. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-6.
10. Massie AB, Segev DL. MELD trajectory prior to death on the liver transplant waitlist. Am J Transplant 2013; 13: 89-90.
11. Knaus WA, Harrell FE, Lynn J, et al. The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1995; 122: 191-203.
12. Charlson ME, Hollenberg JP, Hou J, et al. Realizing the potential of clinical judgment: a real-time strategy for predicting outcomes and cost for medical inpatients. Am J Med 2000; 109: 189-95.